Form 4 for BCDA BioCardia, Inc.
Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-16 · accession 0001437749-22-029316 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-19 | 2022-12-16 | BCDA | Altman Peter | Pres, CEO, Dir | A - Grant | $1.68 | +14.9K | 347.8K | +4% | +$25.0K |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-16 | A | A | 14,880 | $1.68 | 347,827 | D | — | — | (F1) These shares were purchased from the Issuer in a private placement that closed on December 16, 2022. |